HCW Biologics Inc. - HCWB

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$170K
QoQ value delta ($000)
-$248K (-59.33%)
Implied price effect (QoQ)
-61.81%
Shares
Total shares
465,274
QoQ shares delta
+28,340 (+6.49%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (HCWB)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 15 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
HRT FINANCIAL LP 95 266,393 0.0%
Virtu Financial LLC 17 47,809 0.0%
VANGUARD GROUP INC 14 15,426 0.0%
GEODE CAPITAL MANAGEMENT, LLC 12 35,886 0.0%
CITADEL ADVISORS LLC 9 26,083 0.0%
Tower Research Capital LLC (TRC) 5 14,839 0.0%
JANE STREET GROUP, LLC 5 14,134 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 4 12,023 0.0%
CITIGROUP INC 3 10,528 0.0%
UBS Group AG 3 9,221 0.0%
Golden State Wealth Management, LLC 3 10,000 0.0%
WELLS FARGO & COMPANY/MN 0 1,000 0.0%
OSAIC HOLDINGS, INC. 0 26 0.0%
VANGUARD FIDUCIARY TRUST CO 0 1,903 0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0 2 0.0%
SBI Securities Co., Ltd. 0 1 0.0%